NCT01727024View on ClinicalTrials.gov

Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Tiotropium

Tiotropium via Respimat® device once a day

DRUG

Indacaterol

Indacaterol via Breezhaler® device once a day

Trial Locations (10)

74110-030

Novartis Investigative Site, Goiânia

30130-100

Novartis Investigative Site, Belo Horizonte

30150-281

Novartis Investigative Site, Belo Horizonte

20551-030

Novartis Investigative Site, Rio de Janeiro

90020-090

Novartis Investigative Site, Porto Alegre

90610-000

Novartis Investigative Site, Porto Alegre

88040-970

Novartis Investigative Site, Florianópolis

14048-900

Novartis Investigative Site, Ribeirão Preto

01224-000

Novartis Investigative Site, São Paulo

04039-004

Novartis Investigative Site, São Paulo

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY